Skip to main content

Psoriasis

Psoriasis

Center of Excellence

Leaders in the field sharing authoritative insights and institutional best practices
NPF Endorsed Features
Certain comorbidities—particularly congestive heart failure, tuberculosis, and HIV infection—can affect the type of psoriasis treatment physicians recommend to their patients.
NPF Endorsed Features
Access restrictions to therapies among patients with rheumatoid arthritis and psoriatic arthritis can significantly impact treatment effectiveness and adherence. Natalie Boytsov, PhD, discussed the implications of these restrictions with The Dermatologist.
Features
Lawrence Green, MD, shares his perspective on a recent article that showed step therapy and prior authorizations negatively impacted patient care and treatment adherence.  
Features
While anti-tumor necrosis factor (TNF) inhibitors are effective treatments for patients with several inflammatory diseases, they may be associated with new onset psoriatic eruptions or paradoxical worsening of preexisting psoriatic skin disease. In an interview with The Dermatologist, Lourdes M. Perez-Chada, MD, MMSc, Sara Jiayang Li, BS, and Joseph F. Merola, MD, MMSc, discuss a novel treatment algorithm for managing patients treated with anti-TNF inhibitors who develop this adverse event.
NPF Endorsed Features
The palmoplantar form of psoriasis affects roughly a quarter of those with moderate to severe symptoms and presents unique treatment challenges.
NPF Endorsed Features
The National Psoriasis Foundation is collaborating in a real-world trial evaluating the safety and effectiveness of home vs office phototherapy with the goals of providing important data for this therapeutic option and supporting patient-centered research. Dermatology practices can volunteer to act as clinical sites.
Features
Test your knowledge of psoriatic disease.
Features
The association between psoriasis and cardiovascular risk has been well established, yet screening and management still lags behind. Here is what dermatologists should know.
NPF Endorsed Features
Although these drugs frequently are highly effective at treating psoriasis, prescribing them is only half the battle. Dermatologists and patients both face other challenges to access.
NPF Endorsed Features
About 30% of patients with psoriasis will develop this chronic, inflammatory comorbidity. Knowing how to recognize and treat it can help improve patient outcomes.
Back to Top